Gene · 9760
TOX: thymocyte selection associated high mobility group box
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. TOX: thymocyte selection associated high mobility group box. Genes, record 9760. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/9760
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O94900 | Thymocyte selection-associated high mobility group box protein TOX | 526 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents61
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4805378 A1 | 2026-09-16 | 104 | O94900 | Espacenet |
| JP 2026523341 A | 2026-07-14 | 563 | O94900 | Espacenet |
| EP 4771137 A1 | 2026-07-08 | 101 | O94900 | Espacenet |
| EP 4771157 A1 | 2026-07-08 | 101 | O94900 | Espacenet |
| US 12649003 B2 | 2026-06-09 | 563 | O94900 | Espacenet |
| JP 2026510339 A | 2026-04-02 | 101 | O94900 | Espacenet |
| EP 4713451 A2 | 2026-03-25 | 101 | O94900 | Espacenet |
| EP 4713452 A2 | 2026-03-25 | 101 | O94900 | Espacenet |
| US 12558437 B2 | 2026-02-24 | 563 | O94900 | Espacenet |
| EP 4677082 A2 | 2026-01-14 | 101 | O94900 | Espacenet |
1 to 10 of 61
See all 61 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,689
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | TOX papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 30 | 2025 |
| U19AI082630 | Durable Alteration of the Human Immune system after Infection or Immunotherapy | 16 | 2025 |
| P01AI108545 | Synergies among inhibitory receptors in tolerance and disease | 13 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 13 | 2025 |
| P30CA016520 | Abramson Cancer Center Support Grant | 11 | 2025 |
| P30CA076292 | Moffitt Cancer Center Support Grant | 10 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 8 | 2025 |
| R01CA237311 | EPIGENETIC REPROGRAMMING OF T CELL EXHAUSTION TO ENHANCE TUMOR IMMUNOTHERAPY | 7 | 2025 |
| P01CA214278 | Enhancing Chimeric Antigen Receptor T Cell Therapies for HematologicMalignancies: Beyond CART 19 | 6 | 2025 |
| P30CA016042 | Cancer Center Support Grant | 6 | 2025 |
1 to 10 of 1,689Source NIH's project files
See all 1,689 nih grantsPapers2,030
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advanced-stage cutaneous T-cell lymphomas show distinct immune profiles in erythroderma vs. tumor lesions. | J Dermatol Sci | 2026 | 42810908 | PubTator, text mining | PubMed |
| TIGIT regulates CD8+T cell exhaustion via the PI3K/AKT-FOXO1-TOX axis in extrahepatic cholangiocarcinoma. | Clin Immunol | 2026 | 42810560 | PubTator, text mining | PubMed |
| T cell exhaustion in sepsis: mechanisms, biomarkers, and immune-reversal strategies. | Front Immunol | 2026 | 42756179 | PubTator, text mining | PubMed |
| Checkpoint-enriched T cells with retained effector-associated features are associated with disease activity in systemic lupus erythematosus. | Front Immunol | 2026 | 42746266 | PubTator, text mining | PubMed |
| Immune dysregulation and stem-like CD8+ T cell enrichment in type 1 diabetes pancreatic lymph nodes. | J Clin Invest | 2026 | 42741944 | PubTator, text mining | PubMed |
| ANKRD11 deficiency reprograms CD8+ T cell differentiation to enhance immunity in chronic infection and cancer. | Nat Immunol | 2026 | 42728401 | PubTator, text mining | PubMed |
| Disulfidptosis as an immunometabolic rheostat in gastrointestinal cancers: tuning the balance between T Cell exhaustion and immunogenic cell death. | Front Cell Dev Biol | 2026 | 42724329 | PubTator, text mining | PubMed |
| High HBV antigen levels drive loss of vaccine-induced CD8+ T-cell function in carrier mice over time. | JHEP Rep | 2026 | 42722105 | PubTator, text mining | PubMed |
| Corrigendum to 'TOX promotes the exhaustion of antitumor CD8+ T cells by preventing PD1 degradation in hepatocellular carcinoma' [J hepatol (2019) 71(4):731-741; doi: 10.1016/j.jhep.2019.05.015]. | J Hepatol | 2026 | 42711201 | PubTator, text mining | PubMed |
| Hypoxia induces cytotoxicity and suppresses cytokine production by CD8□ T cells in cutaneous leishmaniasis. | bioRxiv | 2026 | 42620055 | PubTator, text mining | PubMed |
1 to 10 of 2,030
See all 2,030 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/9760
GET https://conductscience.org/api/genes/v1/9760/patents?page=2